Schellinger, Peter D.

Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke

Ehrenreich, H., Weissenborn, K., Prange, H., Schneider, D., Weimar, C., Wartenberg, K., Schellinger, P. D., Bohn, M., Becker, H., Wegrzyn, M., et al. (2009) · Stroke

Erythropoietin and Anemia TreatmentAcute Ischemic Stroke Management

Cited by 605

Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage

Kuramatsu, J. B., Gerner, S. T., Schellinger, P. D., Glahn, J., Endres, M., Sobesky, J., Flechsenhar, J., Neugebauer, H., Jüttler, E., Grau, A., et al. (2015) · JAMA

Intracerebral and Subarachnoid Hemorrhage ResearchAcute Ischemic Stroke Management

Cited by 568

Statistical Analysis of the Primary Outcome in Acute Stroke Trials

Bath, P. M. W., Lees, K. R., Schellinger, P. D., Altman, H., Bland, M., Hogg, C., Howard, G., & Saver, J. L. (2012) · Stroke

Acute Ischemic Stroke ManagementVenous Thromboembolism Diagnosis and Management

Cited by 266

Contemporary Outcome Measures in Acute Stroke Research: Choice of Primary Outcome Measure

Lees, K. R., Bath, P. M. W., Schellinger, P. D., Kerr, D. M., Fulton, R., Hacke, W., Matchar, D., Sehra, R., & Toni, D. (2012) · Stroke

Acute Ischemic Stroke ManagementStroke Rehabilitation and Recovery

Cited by 242

Neurological manifestations and implications of COVID-19 pandemic

Tsivgoulis, G., Palaiodimou, L., Katsanos, A. H., Caso, V., Köhrmann, M., Molina, C., Cordonnier, C., Fischer, U., Kelly, P., Sharma, V. K., et al. (2020) · Therapeutic Advances in Neurological Disorders

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 145